Sharon Saban - 18 Mar 2026 Form 3 Insider Report for Nano-X Imaging Ltd. (NNOX)

Reporting relationship: General Manager AI Division
Issuer ticker: NNOX
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 07 Apr 2026, 08:39:56 UTC
Source filing: View source filing
Reporting owner signature: /s/ Marina Gofman Feler, attorney-in-fact

Key filing fact

Sharon Saban filed Form 3 for Nano-X Imaging Ltd. (NNOX) on 07 Apr 2026.

Key facts

This page summarizes Sharon Saban's Form 3 filing for Nano-X Imaging Ltd. (NNOX).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2026, 08:39.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002124822 Primary reporting owner

saban sharon

Relationship: General Manager AI Division
Address: C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL
Signature: /s/ Marina Gofman Feler, attorney-in-fact
Signature date: 07 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NNOX holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 26,316
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 15,000
Exercise price: $17.63
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on February 5, 2026, of which 50% will vest on the 12-month anniversary of the grant date and the remaining 50% will vest upon the 24-month anniversary of the grant date.

Footnote F2

The options reported in this row were granted to the Reporting Person by the Issuer on September 15, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that grant date (September 15, 2026).

SEC remarks

Exhibit 24.1 Power of Attorney